NCCN issues revised prostate cancer management guidelines for 2016

The National Comprehensive Cancer Consortium (NCCN) has just released its updated 2016 guidelines on the management of prostate cancer for physicians. … READ MORE …

Expectation management and sexual/erectile outcomes after radical prostatectomy

A newly published paper in BJU International has helped to make clear that many surgical patients have unrealistic expectations about their recovery of erectile and sexual function after radical prostatectomy. … READ MORE …

Prostate cancer, cardiovascular disease, and the role of ADT

A new trial to be discussed at the Genitourinary Cancers Symposium is the RADICAL-PC trial, designed to give us a greater understanding of the roles of androgen deprivation (ADT) and other factors in causing cardiovascular disease in high-risk prostate cancer patients. … READ MORE …

Some refreshing truths about erectile function post-surgery

A refreshingly honest article published this year in Translational Andrology and Urology, and reprinted in full on the Medscape web site, offers a somewhat depressing assessment of the state of the art of prevention of erectile dysfunction and/or rehabilitation of erectile function in men undergoing radical prostatectomy. … READ MORE …

What everyone needs to expect about recovery post-surgery

Slowly but surely we are seeing increasing recognition in the clinical community of the need to ensure that prostate cancer patients and their spouses/partners really understand the likely consequences of treatment. … READ MORE …

Prolaris test data change clinician, patient decisions about prostate cancer management

A new paper in the Journal of Urology provides us with some interesting if preliminary information on the ways that genetic/genomic tests of biopsy samples may be affecting first-line treatments for localized forms of prostate cancer. … READ MORE …

What it really costs to manage/treat low-risk prostate cancer

In a new article in the journal Cancer, a research group associated primarily with the University of California, Los Angeles, have provided detailed information on the costs of first-line management of low-risk prostate cancer. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,369 other followers